Graham Capital Management, L.P. Xeris Biopharma Holdings, Inc. Transaction History
Graham Capital Management, L.P.
- $3.11 Billion
- Q2 2024
A detailed history of Graham Capital Management, L.P. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 55,141 shares of XERS stock, worth $185,273. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,141
Previous 86,619
36.34%
Holding current value
$185,273
Previous $191,000
35.08%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
134Shares Held
56.4MCall Options Held
126KPut Options Held
45K-
Black Rock Inc. New York, NY10.3MShares$34.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.66MShares$25.7 Million0.0% of portfolio
-
Caxton Corp Princeton, NJ5.11MShares$17.2 Million61.49% of portfolio
-
Bio Impact Capital LLC Cambridge, MA4.83MShares$16.2 Million1.75% of portfolio
-
State Street Corp Boston, MA3.26MShares$10.9 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $457M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...